BALCHEM CORP (BCPC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 400M 800M 1.2B FY09: 219.4M FY10: 255.1M FY11: 291.9M FY12: 310.4M FY13: 337.2M FY14: 541.4M FY15: 552.5M FY16: 553.2M FY17: 594.8M FY18: 643.7M FY19: 643.7M FY20: 703.6M FY21: 799M FY22: 942.4M FY23: 922.4M FY24: 953.7M FY25: 1B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 150M 300M 450M FY09: 67M FY10: 78M FY11: 86M FY12: 89.5M FY13: 97.4M FY14: 144.2M FY15: 168.1M FY16: 180.9M FY17: 189M FY18: 204.3M FY19: 211.4M FY20: 223.9M FY21: 243.2M FY22: 280.5M FY23: 302.1M FY24: 336.2M FY25: 370.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

0 80M 160M 240M FY09: 40.7M FY10: 49.8M FY11: 56.2M FY12: 59.8M FY13: 65.6M FY14: 82.1M FY15: 94M FY16: 90.8M FY17: 96.9M FY18: 107.1M FY19: 102.6M FY20: 111.1M FY21: 127.5M FY22: 145.2M FY23: 159.2M FY24: 182.9M FY25: 209.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

0 60M 120M 180M FY09: 26.8M FY10: 33.3M FY11: 38.8M FY12: 40M FY13: 44.9M FY14: 52.8M FY15: 59.7M FY16: 56M FY17: 90.1M FY18: 78.6M FY19: 79.7M FY20: 84.6M FY21: 96.1M FY22: 105.4M FY23: 108.5M FY24: 128.5M FY25: 154.8M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 250M 500M 750M FY09: 152.5M FY10: 177M FY11: 205.9M FY12: 220.9M FY13: 239.8M FY14: 397.2M FY15: 384.4M FY16: 372.3M FY17: 405.8M FY18: 439.4M FY19: 432.3M FY20: 479.7M FY21: 555.8M FY22: 661.9M FY23: 620.4M FY24: 617.5M FY25: 666.5M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 80M 160M 240M FY09: 48.1M FY10: 39M FY11: 44.9M FY12: 53.8M FY13: 55.7M FY14: 85.3M FY15: 103.8M FY16: 107.6M FY17: 110.6M FY18: 118.7M FY19: 124.5M FY20: 150.5M FY21: 160.5M FY22: 138.5M FY23: 183.8M FY24: 182M FY25: 216.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 60M 120M 180M FY09: 44.6M FY10: 31.5M FY11: 38.3M FY12: 39.9M FY13: 47.5M FY14: 72.2M FY15: 62.5M FY16: 84.6M FY17: 83.1M FY18: 99.5M FY19: 98.7M FY20: 118.4M FY21: 124.4M FY22: 89.5M FY23: 145.9M FY24: 146.3M FY25: 173.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 15M 30M 45M FY09: 28.9M FY10: 29.6M FY11: 30.2M FY12: 30.4M FY13: 30.8M FY14: 31.2M FY15: 31.6M FY16: 31.9M FY17: 32.2M FY18: 32.4M FY19: 32.5M FY20: 32.5M FY21: 32.7M FY22: 32.4M FY23: 32.4M FY24: 32.7M FY25: 32.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.00 4.00 6.00 Q4 '10: 1.12 Q1 '11: 1.18 Q2 '11: 1.22 Q3 '11: 1.29 Q4 '11: 1.29 Q1 '12: 1.30 Q2 '12: 1.31 Q3 '12: 1.31 Q4 '12: 1.33 Q1 '13: 1.38 Q2 '13: 1.43 Q3 '13: 1.45 Q4 '13: 1.47 Q1 '14: 1.40 Q2 '14: 1.33 Q3 '14: 1.44 Q4 '14: 1.70 Q1 '15: 1.89 Q2 '15: 2.05 Q3 '15: 2.00 Q4 '15: 1.88 Q1 '16: 1.77 Q2 '16: 1.74 Q3 '16: 1.74 Q4 '16: 1.75 Q1 '17: 1.86 Q2 '17: 1.93 Q3 '17: 1.99 Q4 '17: 2.79 Q1 '18: 2.91 Q2 '18: 3.01 Q3 '18: 3.10 Q4 '18: 2.43 Q1 '19: 2.41 Q2 '19: 2.41 Q3 '19: 2.46 Q4 '19: 2.46 Q1 '20: 2.49 Q2 '20: 2.53 Q3 '20: 2.55 Q4 '20: 2.60 Q1 '21: 2.71 Q2 '21: 2.76 Q3 '21: 2.87 Q4 '21: 2.95 Q1 '22: 3.12 Q2 '22: 3.34 Q3 '22: 3.35 Q4 '22: 3.25 Q1 '23: 3.06 Q2 '23: 3.07 Q3 '23: 3.19 Q4 '23: 3.35 Q1 '24: 3.54 Q2 '24: 3.59 Q3 '24: 3.72 Q4 '24: 3.93 Q1 '25: 4.17 Q2 '25: 4.36 Q3 '25: 4.57 Q4 '25: 4.75 Q1 '26: 4.87 Q2 '26: 5.09 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.